Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Esophageal and GI Pathology, and Gastrointestinal Tumor Research and Treatment.
Management of paraesophageal hiatus hernia: recommendations following a European expert Delphi consensus
Dissecting the genetic heterogeneity of gastric cancer
Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors
Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer”
GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level
eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma
Sex-Specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma
Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma
Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study
Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study
B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies
FA01.02: THE EFFECT OF POSTOPERATIVE COMPLICATIONS AFTER MIE ON LONG-TERM SURVIVAL: A RETROSPECTIVE, MULTI-CENTER COHORT STUDY
Defining Benchmarks for Transthoracic Esophagectomy
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
The Barrett‐associated variants at <i><scp>GDF</scp>7</i> and <i><scp>TBX</scp>5</i> also increase esophageal adenocarcinoma risk
International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival
Supportive evidence for <i><scp>FOXP</scp>1</i>,<i><scp>BARX</scp>1</i>, and <i><scp>FOXF</scp>1</i> as genetic risk loci for the development of esophageal adenocarcinoma
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
pT2 Adenocarcinoma of the Esophagus: Early or Advanced Cancer?
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer – Differential treatment strategies for subtypes of early gastroesophageal cancer
Multimodal treatment of esophageal cancer